Differences

This shows you the differences between two versions of the page.

--- covid-19:natural_immunity [2022/01/20 17:27]
robert [CDC Propaganda]
+++ covid-19:natural_immunity [2022/08/18 08:15] (current)
mathew
@@ Line 1: / Line 1: @@
 ====== SARS-CoV-2/COVID-19 Natural Immunity ======
-**[[:COVID-19]] [[:natural immunity]]** is a controversial topic during the [[:COVID-19 pandemic]].
+**[[:COVID-19]] [[:natural immunity]]** is a controversial topic during the [[:COVID-19 pandemic]], perhaps because it conflicts with what appears to be a highly determined plan to mass vaccinate the world.
 ===== Research =====
+==== T Cell Immunity ====
+Both symptomatic and asymptomatic SARS-CoV-2 infections result in T cell responses, with greater interferon-\alpha producing responses from those with symptomatic infections.((March 5, 2021 | Prasanna Jagannathan & Taia Wang | Nature Immunology | Immunity after SARS-CoV-2 infections | [[https://www.nature.com/articles/s41590-021-00923-3|https://doi.org/10.1038/s41590-021-00923-3]]))
 ==== Observational Studies ====
+A group of scientists examined a wide swath of antibody data among Canadians during the first half of 2020 determining that more than 90% of uninfected adults showed preexisting antibody reactivity against SARS-CoV-2.((March 15, 2021 | Majdoubi et al | JCI Insight | A majority of uninfected adults show preexisting antibody reactivity against SARS-CoV-2 | [[https://insight.jci.org/articles/view/146316|DOI:10.1172/jci.insight.146316]]))
 "SARS-CoV-2-naïve vaccinees had a 13.06-fold (95% CI, 8.08 to 21.11) increased risk for breakthrough infection with the Delta variant compared to those previously infected, when the first event (infection or vaccination) occurred during January and February of 2021." Gazit et al., August 2021.((https://www.medrxiv.org/content/10.1101/2021.08.24.21262415v1))